ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DEST Destiny Pharma Plc

3.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Destiny Pharma Plc LSE:DEST London Ordinary Share GB00BDHSP575 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.00 2.50 3.50 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Destiny Pharma Share Discussion Threads

Showing 2976 to 2999 of 3000 messages
Chat Pages: 120  119  118  117  116  115  114  113  112  111  110  109  Older
DateSubjectAuthorDiscuss
04/11/2024
11:31
I've skim-read the documents on Co.s House of 19 October. It's not all over yet by any stretch... Sale negotiations ongoing with "multiple parties". Creditors to be paid in full with the intention to convert to a CVL to allow a dividend payment if appropriate once outcome of sale process is known.
chrysalis99
04/11/2024
08:41
Mystery why Rudd bought 1.2m shares in August.
chrysalis99
28/10/2024
13:46
It's game over! Check Companies House for Administrators update. Such a shame - heaven forbid we end up with an AMR strain that wreaks havoc and yet could have been solved with DEST's product line.
cloudwars
30/8/2024
16:24
I guess it depends if there is more than one interested party. ??? A low ball offer given the stage they've got to could easily go to £50m. I'm sure Tovey wanted to take the big boys on and run with it as a listed entity but that wasn't to be.
cloudwars
30/8/2024
14:04
Ram out of cash and couldn't raise without huge dilution . The company over valued itself and thought it would do better privately but reality was very different . Now it will be sold off for peanuts and the boys probably get jobs with who buys it . Much will have been planned out already imo . Totally shafted shareholders yet again
bones698
30/8/2024
13:47
But given the extensive fundraising/partnership discussions that have taken place over previous months, is a further FDA QIDP designation a significant enough game-changer in terms of interest in funding a commercialisation? And putting the company into administration is unlikely to help their negotiation position, to say the least.
chrysalis99
29/8/2024
16:41
Because he knew of the pending FDA status re XF Dermal
cloudwars
29/8/2024
13:56
Administration may have been a prudent move given the circumstances and it does not necessarily mean game over for shareholders
timbo003
29/8/2024
13:28
That's the mystery. Why did Rudd buy a big chunk of shares a few weeks before the board put the company into administration?
chrysalis99
28/8/2024
19:11
Why not contact JP Jenkins the broker who are dealing on a matched market basis who may have a seller for your request
oliversydney
28/8/2024
16:39
I’m in the market for a few
100k at 3
Anyone ?

washingmachine
28/8/2024
16:37
It may be worth buying a few
If their is any sellers

washingmachine
28/8/2024
16:32
What a snip for Sebala this might me. If sizeable Royalties are down the road (IF) why not nip them in the bud and acquire Dest......
carlisle44
28/8/2024
12:55
I think the share holders will be alright as the company had money in the bank and little in the way of debt.Also I doubt that Nigel Rudd would have bought a large chunk of shares in the market only to see it vanish a few weeks later
And the FDA approval today is big news

oliversydney
28/8/2024
11:41
Still activity and interest despite the company now being delisted and in administration, although I'm not sure that shareholders will end up with much (or anything) even if the administrators achieve an optimal outcome:




It is good to see that there is renewed interest in inhaled XF drugs for Cystic Fibrosis, I have always thought that CF might be the best way in for first approval and the news today concerning QIDP status for XF-73 Dermal to treat burn wound infections will help attract interest from potential investors or acquirers

timbo003
25/8/2024
08:37
Hats off for calling this correct Bones i must admit with the advance phase 3 products they had i never expected administration.
im guessing pharma simply wasnt interested in the space DEST was working in.
Will be interesting to see who eventually gets hold of the Tech.

Thankfully no damage done, however GL to those who may have taken a hit.

john henry
13/8/2024
09:00
Terminated.
terminator101
12/8/2024
16:25
10p you say. Yet this pile of pish has gone into obscurity without trace.
terminator101
10/8/2024
12:52
GEX:

Next big thing is Helium.

Currently 15p with broker target £321 if they pull it off this December.

Https:

//www.youtube.com/watch?v=uUhiPjkzLGI

batiatus
09/8/2024
11:36
Zen do you think that the issued share capital will be reduced in number too?
carlisle44
09/8/2024
10:31
Personally I think they already have a pre-agreement in place with an investor(s), otherwise why would one go through all the pain and cost of delisting on a suggestion. After delisting I suspect magically funding to arrive.
zen12
09/8/2024
09:51
I've bought more and will end up with a share certificate. Any future gains I'm happy to pay tax on.
cloudwars
09/8/2024
07:25
Some interesting posts on the Lse forum. Holding these delisted shares could be problematic. I've sold.
jias
06/8/2024
12:14
If they get this right then they'll get the funding - probably from the US via p.e - get Phase 3 completed and then look to list on the NASDAQ - I've bought in from low levels and am happy to tuck these away for a few years.
cloudwars
Chat Pages: 120  119  118  117  116  115  114  113  112  111  110  109  Older

Your Recent History

Delayed Upgrade Clock